Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "Novartis"

118 News Found

Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study
Biotech | April 27, 2022

Tislelizumab plus chemo show promising results for esophageal cancer in Phase III study

Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours


CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer
Biotech | April 23, 2022

CHMP adopts positive opinion on Tabrecta for advanced non-small cell lung cancer

With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients


JBCPL buys Azmarda trademark for India at Rs 246 crore
News | April 03, 2022

JBCPL buys Azmarda trademark for India at Rs 246 crore

The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.


Dr. Reddy's to acquire cardiovascular brand Cidmus in India
News | April 01, 2022

Dr. Reddy's to acquire cardiovascular brand Cidmus in India

The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction


PHARMAP 2022 to discuss contemporary issues
News | March 25, 2022

PHARMAP 2022 to discuss contemporary issues

The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies


Zolgensma used pre-symptomatically enables kids to stand and walk
Biotech | March 14, 2022

Zolgensma used pre-symptomatically enables kids to stand and walk

Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection


SPAG appoints Ritika Jauhari as President- Strategy & New Business
People | March 14, 2022

SPAG appoints Ritika Jauhari as President- Strategy & New Business

Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur


Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada
People | March 09, 2022

Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada

With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies


GSK introduces Haleon to the world
News | February 23, 2022

GSK introduces Haleon to the world

Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum


Complement Therapeutics raises €5 million seed financing
News | February 23, 2022

Complement Therapeutics raises €5 million seed financing

Appoints Dr Rafiq Hasan as CEO